See more : Wuxi Lihu Corporation Limited. (300694.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of ADM Tronics Unlimited, Inc. (ADMT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ADM Tronics Unlimited, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- ValueCommerce Co., Ltd. (2491.T) Income Statement Analysis – Financial Results
- AGS Corporation (3648.T) Income Statement Analysis – Financial Results
- Collins Foods Limited (CLLFF) Income Statement Analysis – Financial Results
- Nittoc Construction Co., Ltd. (1929.T) Income Statement Analysis – Financial Results
- Rajasthan Petro Synthetics Limited (RAJSPTR.BO) Income Statement Analysis – Financial Results
ADM Tronics Unlimited, Inc. (ADMT)
About ADM Tronics Unlimited, Inc.
ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Electronics, Chemical, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, it provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. The company was incorporated in 1969 and is headquartered in Northvale, New Jersey.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.85M | 3.68M | 3.21M | 3.09M | 3.49M | 3.02M | 3.75M | 5.27M | 4.51M | 2.85M | 1.81M | 1.58M | 2.32M | 1.20M | 1.17M | 1.49M | 1.90M | 1.54M | 1.72M | 1.38M | 1.16M | 1.01M | 1.37M | 1.94M | 2.70M | 2.10M | 1.54M | 1.64M | 1.92M | 1.60M | 1.40M | 2.00M | 1.60M | 900.00K | 800.00K | 700.00K |
| Cost of Revenue | 1.75M | 2.02M | 1.96M | 1.93M | 1.91M | 1.45M | 1.87M | 2.61M | 1.92M | 1.49M | 875.61K | 782.65K | 935.89K | 683.58K | 701.76K | 1.08M | 1.36M | 485.37K | 693.00K | 530.87K | 528.57K | 776.03K | 673.95K | 631.19K | 1.24M | 681.51K | 644.76K | 597.45K | 602.61K | 400.00K | 500.00K | 200.00K | 800.00K | 300.00K | 200.00K | 400.00K |
| Gross Profit | 1.09M | 1.66M | 1.25M | 1.16M | 1.57M | 1.56M | 1.89M | 2.66M | 2.60M | 1.36M | 934.01K | 798.19K | 1.38M | 515.02K | 464.83K | 405.21K | 540.88K | 1.05M | 1.03M | 851.24K | 634.69K | 233.20K | 697.81K | 1.31M | 1.46M | 1.42M | 890.48K | 1.04M | 1.32M | 1.20M | 900.00K | 1.80M | 800.00K | 600.00K | 600.00K | 300.00K |
| Gross Profit Ratio | 38.45% | 45.09% | 38.94% | 37.59% | 45.15% | 51.81% | 50.30% | 50.46% | 57.55% | 47.88% | 51.61% | 50.49% | 59.59% | 42.97% | 39.85% | 27.26% | 28.52% | 68.44% | 59.81% | 61.59% | 54.56% | 23.11% | 50.87% | 67.55% | 54.21% | 67.53% | 58.00% | 63.54% | 68.59% | 75.00% | 64.29% | 90.00% | 50.00% | 66.67% | 75.00% | 42.86% |
| Research & Development | 581.12K | 541.18K | 615.93K | 655.96K | 589.37K | 673.86K | 527.66K | 168.81K | 91.77K | 38.06K | 34.86K | 34.25K | 35.86K | 43.29K | 28.00K | 0.00 | 3.82K | 298.52K | 544.43K | 270.89K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.04K | 0.00 | 1.67M | 1.07M | 923.25K | 0.00 | 1.40M | 1.34M | 2.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 795.40K | 1.09M | 1.76M | 0.00 | 1.01M | 0.00 | 1.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.11M | 1.09M | 1.67M | 1.07M | 1.01M | 1.24M | 1.40M | 1.34M | 2.24M | 1.07M | 1.08M | 1.28M | 1.45M | 1.08M | 947.74K | 1.11M | 1.18M | 4.37M | 5.47M | 2.58M | 720.17K | 952.18K | 1.15M | 1.66M | 2.03M | 2.16M | 1.61M | 1.01M | 992.11K | 1.00M | 800.00K | 1.10M | 1.00M | 1.20M | 1.00M | 800.00K |
| Other Expenses | 203.69K | 0.00 | 88.34K | 109.56K | 22.68K | 22.11K | -1.38M | 11.77K | 3.96K | 3.61K | 46.30K | 21.17K | 92.21K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 139.21K | 0.00 | 0.00 | 0.00 | 252.74K | -126.86K | -40.64K | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 |
| Operating Expenses | 1.70M | 1.63M | 2.38M | 1.83M | 1.62M | 1.94M | 1.95M | 1.52M | 2.33M | 1.12M | 1.16M | 1.34M | 1.57M | 1.12M | 975.74K | 1.11M | 1.18M | 4.67M | 6.01M | 2.99M | 720.17K | 952.18K | 1.15M | 1.91M | 1.91M | 2.12M | 1.61M | 1.01M | 992.11K | 1.10M | 900.00K | 1.20M | 1.10M | 1.30M | 1.10M | 800.00K |
| Cost & Expenses | 3.45M | 3.65M | 4.34M | 3.76M | 3.53M | 3.39M | 3.82M | 4.13M | 4.25M | 2.60M | 2.03M | 2.12M | 2.51M | 1.81M | 1.68M | 2.19M | 2.54M | 5.16M | 6.71M | 3.53M | 1.25M | 1.73M | 1.83M | 2.54M | 3.14M | 2.80M | 2.26M | 1.61M | 1.59M | 1.50M | 1.40M | 1.40M | 1.90M | 1.60M | 1.30M | 1.20M |
| Interest Income | 28.68K | 13.09K | 3.01K | 14.59K | 25.58K | 26.95K | 17.63K | 3.15K | 4.41K | 301.00 | 4.81K | 4.92K | 6.21K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 23.20K | 18.94K | 15.60K | 10.39K | 8.42K | 8.81K | 6.71K | 4.95K | 6.06K | 6.23K | 6.23K | 3.77K | 4.50K | 3.52K | 6.68K | 43.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 37.68K | 36.93K | 110.27K | 164.12K | 39.56K | 39.06K | 39.27K | 17.54K | 5.02K | 5.02K | 46.30K | 21.17K | 43.40K | 43.09K | 62.35K | 38.22K | 19.25K | 1.71M | 778.06K | 306.32K | 147.48K | 185.58K | 217.53K | 252.74K | 258.53K | 160.14K | 64.74K | 27.25K | 0.00 | -100.00K | -100.00K | -100.00K | -100.00K | 100.00K | 100.00K | -100.00K |
| EBITDA | -514.03K | 80.35K | -1.02M | -506.36K | 21.75K | -308.72K | -9.28K | 1.16M | 272.41K | 255.27K | -172.69K | -512.20K | -96.17K | -565.48K | 266.44K | 9.99M | -623.66K | -1.53M | -3.91M | -1.93M | 114.26K | -598.49K | -239.30K | -346.74K | -186.42K | -545.30K | -658.04K | 54.01K | 323.93K | 100.00K | 100.00K | 1.20M | -200.00K | -700.00K | -500.00K | -600.00K |
| EBITDA Ratio | -18.07% | 2.19% | -31.78% | -16.38% | 0.62% | -10.23% | -0.25% | 21.99% | 6.04% | 8.96% | -9.54% | -32.40% | -4.15% | -47.18% | 22.84% | 672.20% | -32.88% | -99.47% | -226.96% | -139.89% | 9.82% | -59.30% | -17.44% | -17.83% | -6.91% | -25.98% | -42.86% | 3.30% | 16.88% | 6.25% | 7.14% | 60.00% | -12.50% | -77.78% | -62.50% | -85.71% |
| Operating Income | -601.52K | 43.43K | -1.13M | -670.48K | -17.81K | -374.72K | -66.19K | 1.14M | 262.98K | 249.95K | -223.79K | -538.28K | -194.59K | -608.57K | -510.91K | -707.49K | -642.92K | -3.62M | -4.98M | -2.14M | -85.48K | -718.99K | -456.82K | -599.49K | -444.95K | -705.44K | -722.78K | 26.75K | 323.93K | 100.00K | 200.00K | 600.00K | -300.00K | -700.00K | -500.00K | -500.00K |
| Operating Income Ratio | -21.14% | 1.18% | -35.22% | -21.69% | -0.51% | -12.41% | -1.76% | 21.60% | 5.83% | 8.77% | -12.37% | -34.05% | -8.40% | -50.77% | -43.79% | -47.60% | -33.90% | -235.24% | -288.92% | -155.10% | -7.35% | -71.24% | -33.30% | -30.82% | -16.49% | -33.61% | -47.08% | 1.63% | 16.88% | 6.25% | 14.29% | 30.00% | -18.75% | -77.78% | -62.50% | -71.43% |
| Total Other Income/Expenses | 2.38K | -18.94K | 681.23K | 4.20K | -8.42K | 18.14K | 10.93K | -1.80K | -1.65K | 114.77K | -1.42K | 1.15K | 1.70K | 3.52K | -715.00K | -10.66M | -2.34M | -1.45M | -290.35K | 96.04K | -52.26K | 65.08K | 153.85K | 0.00 | 0.00 | 0.00 | 0.00 | -20.00K | -279.00K | 100.00K | 0.00 | -500.00K | 0.00 | 100.00K | 100.00K | 100.00K |
| Income Before Tax | -596.04K | 24.49K | -448.08K | -666.28K | -26.24K | -356.58K | -55.26K | 1.14M | 261.34K | 358.79K | -225.21K | -537.13K | -192.88K | -605.05K | -1.22M | -11.32M | -2.98M | -5.07M | -5.27M | -2.05M | -137.74K | -653.91K | -302.98K | -599.49K | 0.00 | -705.44K | -722.78K | 6.75K | 44.93K | 100.00K | 0.00 | 200.00K | 0.00 | -600.00K | -400.00K | -400.00K |
| Income Before Tax Ratio | -20.95% | 0.67% | -13.97% | -21.56% | -0.75% | -11.81% | -1.47% | 21.57% | 5.79% | 12.59% | -12.45% | -33.98% | -8.33% | -50.48% | -104.51% | -761.92% | -157.25% | -329.37% | -305.76% | -148.15% | -11.84% | -64.79% | -22.09% | -30.82% | 0.00% | -33.61% | -47.08% | 0.41% | 2.34% | 6.25% | 0.00% | 10.00% | 0.00% | -66.67% | -50.00% | -57.14% |
| Income Tax Expense | 132.30K | 120.81K | 936.18K | -68.00K | 69.52K | -14.00K | -165.00K | -69.00K | -857.00K | 6.23K | 4.81K | 4.92K | -169.52K | 0.00 | 708.32K | -2.43M | -88.32K | 3.48M | 2.19M | 180.76K | 52.26K | -65.08K | 0.00 | 0.00 | 0.00 | 265.00K | 0.00 | 0.00 | -153.00K | -100.00K | 0.00 | 100.00K | 200.00K | -100.00K | 0.00 | 0.00 |
| Net Income | -716.85K | -96.32K | -1.38M | -598.28K | -95.76K | -342.58K | 109.74K | 1.21M | 1.12M | 358.79K | -225.21K | -537.13K | -23.36K | -605.05K | -1.22M | -8.90M | -2.89M | -8.17M | -7.17M | -2.32M | -137.74K | -653.91K | -302.98K | -599.49K | -444.95K | -970.44K | -722.78K | 6.75K | 197.93K | 200.00K | 0.00 | 200.00K | -300.00K | -600.00K | -500.00K | -400.00K |
| Net Income Ratio | -25.19% | -2.62% | -43.17% | -19.36% | -2.75% | -11.35% | 2.92% | 22.87% | 24.78% | 12.59% | -12.45% | -33.98% | -1.01% | -50.48% | -104.51% | -598.75% | -152.59% | -530.99% | -415.89% | -168.18% | -11.84% | -64.79% | -22.09% | -30.82% | -16.49% | -46.23% | -47.08% | 0.41% | 10.32% | 12.50% | 0.00% | 10.00% | -18.75% | -66.67% | -62.50% | -57.14% |
| EPS | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 | -0.01 | 0.00 | -0.01 | -0.02 | -0.16 | -0.05 | -0.15 | -0.13 | -0.04 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.02 | -0.01 | 0.00 | -0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 | -0.01 | 0.00 | -0.01 | -0.02 | -0.16 | -0.05 | -0.15 | -0.13 | -0.04 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.15M | 66.28M | 64.94M | 64.94M | 57.49M | 56.94M | 54.54M | 53.94M | 53.94M | 53.94M | 53.88M | 53.88M | 52.55M | 51.01M | 48.13M | 47.38M | 47.38M | 47.38M | 46.78M | 42.48M | 43.30M | 43.87M | 42.48M | 42.48M | 30.00M | 30.00M | 30.00M | 50.00M | 40.00M |
| Weighted Avg Shares Out (Dil) | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.15M | 66.28M | 65.54M | 65.54M | 57.49M | 56.94M | 54.54M | 53.94M | 53.94M | 53.94M | 53.88M | 53.88M | 52.55M | 51.01M | 48.13M | 47.38M | 47.38M | 47.38M | 46.78M | 42.48M | 43.30M | 43.87M | 42.48M | 42.48M | 30.00M | 30.00M | 30.00M | 50.00M | 40.00M |
ADM Tronics Reports Second Quarter of Fiscal Year 2025 Results
NORTHVALE, NJ / ACCESSWIRE / November 14, 2024 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2024 of Fiscal Year 2025. The...
ADM Tronics Reports First Quarter of Fiscal Year 2025 Results
NORTHVALE, NJ / ACCESSWIRE / August 19, 2024 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its first fiscal quarter ended June 30, 2024 of Fiscal Year 2025. ADMT...
ADM Tronics Reports Fiscal Year 2024
NORTHVALE, NJ / ACCESSWIRE / July 15, 2024 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies, products, and proprietary medical devices, announces results for fiscal year ended March 31, 2024. During the fiscal year...
ADM Tronics Shareholder Video Conference Replay Available Now for Viewing Online with Update on Vet-Sonotron Veterinary Pain Treatment Technology
NORTHVALE, NJ / ACCESSWIRE / April 23, 2024 / ADM Tronics (OTCQB:ADMT), an innovator of electronic medical device technologies, recently conducted a virtual Shareholder Video Conference during which shareholders were presented with an update on ADMT's new proprietary Vet-Sonotron®, non-invasive...
ADM Tronics to Host Shareholder Video Call on March 27 to Update Launch and Significance of Vet-Sonotron Veterinary Pain Treatment Device
NORTHVALE, NJ / ACCESSWIRE / March 20, 2024 / ADM Tronics (OTCQB:ADMT), an innovator of electronic medical device technologies, invites shareholders to a shareholder video call on March 27, 2024 at 2 PM Eastern, where shareholders will be updated about...
ADM Tronics' Vet-Sonotron(R) Veterinary Pain Treatment Device Now in Production and Already Receiving Pre-Orders
NORTHVALE, NJ / ACCESSWIRE / February 5, 2024 / ADM Tronics (OTCQB:ADMT) an innovator in medical and therapeutic technology, has completed extensive R&D and commenced production of its Vet-Sonotron non-invasive pain treatment device for the veterinary market. The Vet-Sonotron has...
Novel Therapeutic Technology Developed & Manufactured by ADM Tronics for Origin Life Sciences to Begin Clinical Study on Onychomycosis
NORTHVALE, NJ / ACCESSWIRE / December 5, 2023 / ADM Tronics (OTCQB:ADMT) announced that its client, Origin Life Sciences, Inc. ("Origin") is about to launch an IRB-approved pilot clinical study to evaluate the treatment of onychomycosis with its plasma-generated nitric...
ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy Device
NORTHVALE, NJ / ACCESSWIRE / November 28, 2023 / ADM Tronics (OTCQB:ADMT) an innovator in medical and therapeutic technology, is pleased to announce its upcoming commercial launch of the Vet-Sonotron®, non-invasive veterinary therapy device, for non-drug treatment of pain. This...
ADM Tronics Reports Second Quarter of Fiscal Year 2024 Results
NORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2023 of Fiscal Year 2024. During...
ADM Tronics Reports First Quarter of Fiscal Year 2024 Results
NORTHVALE, NJ / ACCESSWIRE / August 14, 2023 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its first fiscal quarter ended June 30, 2023 of Fiscal Year 2024. Revenues...
Source: https://incomestatements.info
Category: Stock Reports